REFERENCES
- Korean Network for Organ Sharing. KONOS 2009 annual report. Available at www.konons.go.kr. Accessed August 21, 2010.
- Huh KH, Kim MS, Ju MK, Exchange living-donor kidney transplantation: Merits and limitations. Transplantation. 2008;86:430–435.
- Hume DM, Merrill JP, Miller BF, Thorn GW. Experiences with renal homotransplantation in the human: Report of nine cases. J Clin Invest. 1955;34:327–382.
- Alexandre GP, De Bruyere M, Squifflet JP, Moriau M, Latinne D, Pirson Y. Human ABO-incompatible living donor renal homografts. Neth J Med. 1985;28:231–234.
- Rahman T, Harper L. Plasmapheresis in nephrology: An update. Curr Opin Nephrol Hypertens. 2006;15:603–609.
- Montgomery RA. Renal transplantation across HLA and ABO antibody barriers: Integrating paired donation into desensitization protocols. Am J Transplant. 2010;10:449–457.
- Tobian AA, Shirey RS, Montgomery RA, Tisch DJ, Ness PM, King KE. Therapeutic plasma exchange reduces ABO titers to permit ABO-incompatible renal transplantation. Transfusion. 2009;49:1248–1254.
- Solez K, Colvin RB, Racusen LC, Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant. 2008;8:753–760.
- Gloor JM, Lager DJ, Moore SB, ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation. 2003;75:971–977.
- Shimmura H, Tanabe K, Ishikawa N, Tokumoto T, Takahashi K, Toma H. Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation. 2000;70:1331–1335.
- Shimmura H, Tanabe K, Ishida H, Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression. Transplantation. 2005;80:985–988.
- Uchida J, Iwai T, Kato M, A novel approach to successful ABO-incompatible high-titer renal transplantation. Transplant Proc. 2008;40:2285–2288.
- Gloor JM, Lager DJ, Fidler ME, A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation. 2005;80:1572–1577.
- Vieira CA, Agarwal A, Book BK, Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics. Transplantation. 2004;77:542–548.
- Toki D, Ishida H, Horita S, Setoguchi K, Yamaguchi Y, Tanabe K. Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients. Transpl Int. 2009;22:447–454.
- Setoguchi K, Ishida H, Shimmura H, Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation. Am J Transplant. 2008;8:86–94.
- Haas M, Segev DL, Racusen LC, C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol. 2009;20:197–204.
- Shimmura H, Tanabe K, Tokumoto T, Impact of HLA-identity on results of ABO-incompatible living kidney transplantation. Transplant Proc. 2004;36:2172–2174.
- Grim SA, Pham T, Thielke J, Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients. Clin Transplant. 2007;21:628–632.
- Aikawa A, Ohara T, Arai K, Clinical outcome and accommodation in ABO incompatible kidney transplantation. Clin Transplant. 2004;1:135–142.